Clinical trial
Assessment of Anatomical and Functional Outcomes in Patients Treated With Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion (VMT/sVMA)
NCT02035748 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Anatomical and Functional Outcomes in Patients Treated With Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion (VMT/sVMA)
- Lead sponsor
- Alcon Research
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2014
- Completion date
- September 30, 2015
- Enrollment
- 628 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
vitreomacular adhesion, vitreomacular traction